Zhiqiang Hu

Zhiqiang Hu

Auto-generated profile, based on publicly available information

Zhiqiang Hu

Zhejiang Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2025 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
YDYuran Duan
Yuran Duan
ZHZhiqiang Hu
Zhiqiang Hu
PHPeng Han
Peng Han
BLBo Lei
Bo Lei
SWShuo Wang
Shuo Wang
DXDaqian Xu
Daqian Xu

25 April 2025 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
PZPeixiang Zheng
Peixiang Zheng
ZHZhiqiang Hu
Zhiqiang Hu
YSYuli Shen
Yuli Shen
LGLina Gu
Lina Gu
YOYuan Ouyang
Yuan Ouyang
DXDaqian Xu
Daqian Xu

23 June 2023 in Science Advances
Verified
Journal Article
Open access
ZHZhiqiang Hu
Zhiqiang Hu
YXYingchao Xie
Yingchao Xie
JLJiansen Lu
Jiansen Lu
JYJianwu Yang
Jianwu Yang
JZJiahuan Zhang
Jiahuan Zhang
XYXiao Yu
Xiao Yu
Stringent control of type I interferon (IFN-I) signaling is critical to potent innate immune responses against viral infection, yet the underlying molecular mechanisms are still elusive. Here, we found that Van Gogh–like 2 (VANGL2) acts as an IFN-inducible negative feedback regulator to suppress IFN-I signaling during vesicular stomatitis virus (VSV) infection. Mechanistically, VANGL2 interacted with TBK1 and promoted the selective autophagic degradation of TBK1 via K48-linked polyubiquitination at Lys 372 by the E3 ligase TRIP, which serves as a recognition signal for the cargo receptor OPTN. Furthermore, myeloid-specific deletion of VANGL2 in mice showed enhanced IFN-I production against VSV infection and improved survival. In general, these findings revealed a negative feedback loop of IFN-I signaling through the VANGL2-TRIP-TBK1-OPTN axis and highlighted the cross-talk between IFN-I and autophagy in preventing viral infection. VANGL2 could be a potential clinical therapeutic target for viral infectious diseases, including COVID-19.

1 July 1999 in Nuclear Physics A
Verified
Journal Article
Closed access
AAA. Algora
A. Algora
DCDaniel Cano-Ott
Daniel Cano-Ott
BRB. Rubio
B. Rubio
JTJ.L. Tain
J.L. Tain
JAJ. Agramunt
J. Agramunt
VWV. Wittmann
V. Wittmann

6 March 2025 in Journal of Experimental Medicine
Verified
Journal Article
Closed access
WQWenxing Qin
Wenxing Qin
YDYuran Duan
Yuran Duan
ZHZhiqiang Hu
Zhiqiang Hu
YHYueru Hou
Yueru Hou
TWTing Wen
Ting Wen
DXDaqian Xu
Daqian Xu
Hypoxia induces immunosuppressive phenotypes in tumor cells even in the presence of cytosolic DNA accumulation. The mechanisms by which tumor cells suppress hypoxia-induced cGAS-STING activation for immune evasion remain largely unclear. Here, we demonstrate that hypoxic stimulation induces JNK1/2-mediated S151 phosphorylation of phosphoenolpyruvate carboxykinase 1 (PCK1), a rate-limiting enzyme in gluconeogenesis. This phosphorylation triggers the interaction between PCK1 and cGAS. The PCK1 associated with cGAS competitively consumes GTP, a substrate shared by both PCK1 and cGAS. Consequently, PCK1 inhibits GTP-dependent cGAS activation and subsequent STING-promoted immune cell infiltration and activation in the tumor microenvironment, leading to promoted tumor growth in mice. The blockade of PCK1 function, in combination with anti–PD-1 antibody treatment, exhibits an additive therapeutic effect on tumor growth. Additionally, PCK1 S151 phosphorylation is inversely correlated with cGAS-STING activation in human breast cancer specimens and patient survival. These findings reveal a novel regulation of cGAS-STING pathway and uncover the metabolic control of immune response in tumor cells.

27 May 2026 in Nature Chemical Biology
Verified
Journal Article
Closed access
ZHZhiqiang Hu
Zhiqiang Hu
WLWei Lv
Wei Lv
TWTing Wen
Ting Wen
JSJunyi Sun
Junyi Sun
GJGuimei Ji
Guimei Ji
DXDaqian Xu
Daqian Xu